A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.

@article{Doruk2008APS,
  title={A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.},
  author={Ali Doruk and Ozcan Uzun and Aytekin Ozşahin},
  journal={International clinical psychopharmacology},
  year={2008},
  volume={23 4},
  pages={223-7}
}
The focus of this study was the systematic evaluation of the clinical effects of the extract of ginkgo biloba (EGb) as an adjunct to the atypical antipsychotic clozapine in the treatment of refractory schizophrenia. In a placebo-controlled study, 42 patients with chronic, treatment-resistant schizophrenia, who were maintained on optimal doses of clozapine, were administered either 120 mg/day of EGb (N=20) or placebo (N=22) for 12 weeks. Clinical evaluations with the Brief Psychiatric Rating… CONTINUE READING

From This Paper

Topics from this paper.
6 Citations
0 References
Similar Papers